13F Data
13F filer · CIK 1813845

BIOS Capital Management, LP

Fort Worth, TX · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$41.7M
$-11.2M vs prior
Positions
6
New / sold out
0 / 0
Added / reduced
1 / 2
Turnover
2.2%
buys $1.0M · sells $2.7M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedREIN THERAPEUTICS INC+1,000,000+50.4%+$1.0M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedLANTERN PHARMA INC-615,038-71.1%$-2.6M
ReducedIN8BIO INC-86,848-51.8%$-122.5K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $94.1MQ1 2025: $79.2MQ2 2025: $72.6MQ3 2025: $88.9MQ4 2025: $82.6MQ1 2026: $52.9MQ2 2026: $41.7M
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ACTUATE THERAPEUTICS INCCOM10,049,996$15.4M36.90%
2OPUS GENETICS INCCOM3,683,429$15.1M36.33%
3COGNITION THERAPEUTICS INCCOM6,000,000$6.9M16.56%
4REIN THERAPEUTICS INCCOM NEW2,982,375$3.1M7.44%
5LANTERN PHARMA INCCOM249,397$1.0M2.50%
6IN8BIO INCCOM NEW80,957$114.1K0.27%